4.6 Article

Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biotechnology & Applied Microbiology

N7-methylguanosine modification of lncRNAs in a rat model of hypoxic pulmonary hypertension: a comprehensive analysis

Huan Wang et al.

Summary: This study conducted the first m7G transcriptome-wide analysis of HPH, identifying differentially-expressed m7Gs and significantly upregulated m7G lncRNAs in HPH. Importantly, two HPH-associated m7G lncRNAs, lncXR_591973 and lncXR_592398, were identified for the first time, although further validation of their clinical significance is needed.

BMC GENOMICS (2022)

Review Oncology

Immunotherapies for hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, specifically hepatocellular carcinoma (HCC), is the second leading cause of cancer-related death globally. Traditional treatments involve specific drugs, but the emergence of immune checkpoint inhibitors has revolutionized the management of HCC.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Review Oncology

Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers

Guoying Zhou et al.

Summary: Liver cancer, particularly hepatocellular carcinoma and cholangiocarcinoma, presents challenges in immune-mediated tumour control due to the immunosuppressive tumour microenvironment. Although key co-inhibitory immune checkpoint interactions play a critical role, only a minority of patients respond to monotherapy using approved checkpoint inhibitor antibodies. Further research is needed to identify alternative immune checkpoints and explore combined targeting of co-inhibitory and co-stimulatory pathways to overcome immunosuppression.

BRITISH JOURNAL OF CANCER (2022)

Article Oncology

Correlation analysis of tumor mutation burden of hepatocellular carcinoma based on data mining

Weijie Zhou et al.

Summary: The study revealed a negative correlation between TMB and the prognosis of HCC patients, with worse prognosis in the high TMB group. Analysis of differential gene expression and immune cell distribution showed specific gene expression differences in HCC cells.

JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)

Review Cell Biology

Gene regulation by long non-coding RNAs and its biological functions

Luisa Statello et al.

Summary: Recent studies have shed new light on the biogenesis and functions of long non-coding RNAs (lncRNAs), showcasing their diverse roles in gene regulation and signaling pathways, particularly in the contexts of neuronal disorders, immune responses, and cancer. The discovery of unique biogenesis pathways and subcellular localizations of lncRNAs has opened up potential therapeutic avenues for targeting lncRNAs in various biological and pathophysiological conditions.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

NONCODEV6: an updated database dedicated to long non-coding RNA annotation in both animals and plants

Lianhe Zhao et al.

Summary: NONCODE is a comprehensive database focusing on the collection and annotation of noncoding RNAs, especially long non-coding RNAs (lncRNAs) in animals. The latest version, NONCODEV6, not only covers lncRNAs in plants and animals, but also provides updated human lncRNA-disease relationships, tissue expression profiles and predicted function of lncRNAs in common plants, as well as conservation annotation of lncRNAs at transcript level for 23 plant species.

NUCLEIC ACIDS RESEARCH (2021)

Review Gastroenterology & Hepatology

Treatment strategies for early stage hepatocellular carcinoma: a systematic review and network meta-analysis of randomised clinical trials

Sivesh K. Kamarajah et al.

Summary: This network meta-analysis identified RFA in combination with iodine-125 as a treatment that delivers better RFS and OS in early stage HCC patients, especially for those with solitary HCC. Further evaluation of this technique is warranted in both Asian and Western regions.
Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Article Oncology

Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors

Jeffrey Sum Lung Wong et al.

Summary: The combination of ipilimumab and anti-PD-1 ICIs (nivolumab or pembrolizumab) shows durable antitumor activity and encouraging survival outcomes with acceptable toxicity in patients with advanced HCC who had prior treatment with ICIs, as demonstrated in this study.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Oncology

Use of 6 m6A-relevant lncRNA genes as prognostic markers of primary liver hepatocellular carcinoma based on TCGA database

Xiao-Li Zhu et al.

Summary: This study identified the importance of m6A-related lncRNAs in the prognosis of HCC and established a risk score model to predict patient outcomes. The results showed that patients in the high-risk group had shorter survival times. These findings emphasize the significance of m6A-related lncRNAs in the progression of HCC.

TRANSLATIONAL CANCER RESEARCH (2021)

Article Biochemistry & Molecular Biology

Identification and Validation of a Prognostic Prediction Model of m6A Regulator-Related LncRNAs in Hepatocellular Carcinoma

Chen Jin et al.

Summary: This study investigated the role of m6A regulator-related lncRNA as a prognostic biomarker in patients with HCC. By constructing the prognostic signature m6A-9LPS, the prognosis of HCC patients could be accurately predicted, which can aid in personalized treatment.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Oncology

METTL1 promotes hepatocarcinogenesis via m7G tRNA modification-dependent translation control

Zhihang Chen et al.

Summary: The N-7-methylguanosine (m(7)G) modification is a common transfer RNA (tRNA) modification in humans. Elevated levels of METTL1 and WDR4 in hepatocellular carcinoma (HCC) are associated with advanced tumor stages and poor patient survival. Mechanistically, METTL1-mediated tRNA m(7)G modification promotes the translation of target mRNAs with higher frequencies of m(7)G-related codons, providing new insights into the role of misregulated tRNA modifications in liver cancer.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Article Cell Biology

The long-noncoding RNA SOCS2-AS1 suppresses endometrial cancer progression by regulating AURKA degradation

Fangfang Jian et al.

Summary: Aberrant expression of lncRNA SOCS2-AS1 is found to be associated with endometrial cancer, where it acts as a tumor suppressor by binding to AURKA and promoting its degradation, leading to cell cycle arrest and apoptosis in EC cells. This suggests that SOCS2-AS1 may serve as a prognostic predictor and biomarker for AURKA-inhibitor treatment in EC patients.

CELL DEATH & DISEASE (2021)

Review Oncology

The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma

Soudeh Ghafouri-Fard et al.

Summary: The dysregulation of long non-coding RNAs (lncRNAs) is associated with the pathogenesis of hepatocellular carcinoma (HCC), impacting the expression of tumor suppressor genes and oncogenes, altering cancer-related signaling pathways. The interaction between lncRNAs and miRNAs plays a crucial role in the development of HCC.

FRONTIERS IN ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma

Lili Li et al.

Summary: This study identified potential prognostic m6A methyltransferase-related lncRNAs for hepatocellular carcinoma (HCC) by analyzing gene expression data and different molecular markers. The research revealed that these lncRNAs were not only involved in immune-related biological processes and pathways, but also correlated with tumor microenvironment and expression of immune checkpoints.

BIOSCIENCE REPORTS (2021)

Review Biochemistry & Molecular Biology

Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review

Kyoko Oura et al.

Summary: Liver cancer, specifically hepatocellular carcinoma (HCC), has the fourth highest mortality rate among all cancers worldwide. Despite advancements in systemic therapy, HCC still has a poor prognosis due to drug resistance, recurrence, and metastasis. Recent therapeutic strategies, such as cancer immunosuppressive therapy utilizing immune checkpoint inhibitors (ICIs) and VEGF inhibitors, have shown promise in extending the lives of patients with advanced HCC.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Editorial Material Biochemistry & Molecular Biology

m7G tRNA modification reveals new secrets in the translational regulation of cancer development

Olga Katsara et al.

MOLECULAR CELL (2021)

Article Biochemistry & Molecular Biology

METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation

Esteban A. Orellana et al.

Summary: The study revealed that METTL1 is frequently overexpressed in cancer, affecting tRNA modification and the cell cycle, promoting oncogenesis. Additionally, it was found that overexpression of a specific tRNA can induce oncogenic transformation.

MOLECULAR CELL (2021)

Article Biotechnology & Applied Microbiology

METTL1/WDR4-mediated m7G tRNA modifications and m7G codon usage promote mRNA translation and lung cancer progression

Jieyi Ma et al.

Summary: This study found that the expression levels of tRNA N7-methylguanosine (m7G) methyltransferase complex components METTL1 and WDR4 are significantly elevated in human lung cancer samples and negatively associated with patient prognosis. METTL1 promotes lung cancer growth and invasion through regulation of m7G tRNA modifications, and tRNA modifications and codon usage play an essential function in mRNA translation regulation.

MOLECULAR THERAPY (2021)

Article Cell Biology

MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma

Peng Xia et al.

Summary: The study identified that m7G methyltransferase WDR4 is highly expressed in hepatocellular carcinoma (HCC) and promotes HCC cell proliferation by increasing m7G methylation levels. WDR4 enhances HCC progression by regulating CCNB1 mRNA stability and translation, activating PI3K/AKT, and reducing P53 expression. Additionally, WDR4 was found to play a role in drug resistance and metastasis in HCC.

CELL DEATH & DISEASE (2021)

Review Oncology

Prognostic Role of Tumor Mutational Burden in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

Taobi Huang et al.

Summary: This study conducted a systematic review and meta-analysis to investigate whether tumor mutational burden (TMB) can be used as a prognostic biomarker for cancer patients treated with immune checkpoint inhibitors (ICIs). The results showed that high TMB patients receiving ICIs had significantly better overall survival (OS) and progression-free survival (PFS) compared to low TMB patients. TMB may serve as a promising independent prognostic biomarker for cancer patients undergoing immunotherapy.

FRONTIERS IN ONCOLOGY (2021)

Review Biochemistry & Molecular Biology

The role of RNA m5C modification in cancer metastasis

Qiaofeng Zhang et al.

Summary: Epigenetic modification is crucial in regulating biological processes in eukaryotic cells, particularly in tumor metastasis. Recent studies have focused on the characterization of RNA and DNA methylation, but the mechanisms of RNA m(5)C methylation in cell mobility and metastasis remain unclear.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Review Biochemistry & Molecular Biology

Long Non-Coding RNAs: Potential Biomarkers and Targets for Hepatocellular Carcinoma Therapy and Diagnosis

Donghong Yuan et al.

Summary: Long non-coding RNAs (lncRNAs) play crucial roles in the occurrence and progression of hepatocellular carcinoma (HCC), promoting various biological behaviors of tumor cells and serving as potential biomarkers to predict treatment efficacy and as personalized tools for diagnosis and treatment.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Article Dentistry, Oral Surgery & Medicine

RP11-874J12.4 promotes oral squamous cell carcinoma tumorigenesis via the miR-19a-5p/EBF1 axis

Guo-Min Liu et al.

JOURNAL OF ORAL PATHOLOGY & MEDICINE (2020)

Article Cell Biology

Rocaglates Induce Gain-of-Function Alterations to eIF4A and eIF4F

Jennifer Chu et al.

CELL REPORTS (2020)

Review Biochemistry & Molecular Biology

The role of long noncoding RNAs in hepatocellular carcinoma

Zhao Huang et al.

MOLECULAR CANCER (2020)

Review Biochemistry & Molecular Biology

The potential role of RNA N6-methyladenosine in Cancer progression

Tianyi Wang et al.

MOLECULAR CANCER (2020)

Article Biochemistry & Molecular Biology

Affinity proteomic dissection of the human nuclear cap-binding complex interactome

Yuhui Dou et al.

NUCLEIC ACIDS RESEARCH (2020)

Review Biochemistry & Molecular Biology

Targeted therapy for hepatocellular carcinoma

Ao Huang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Biochemistry & Molecular Biology

METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation

Luca Pandolfini et al.

MOLECULAR CELL (2019)

Article Multidisciplinary Sciences

The yeast scavenger decapping enzyme DcpS and its application for in vitro RNA recapping

Madalee G. Wulf et al.

SCIENTIFIC REPORTS (2019)

Article Genetics & Heredity

METTL1 overexpression is correlated with poor prognosis and promotes hepatocellular carcinoma via PTEN

Qiu-Hong Tian et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2019)

Article Biochemistry & Molecular Biology

Dcp2: an mRNA decapping enzyme that adopts many different shapes and forms

Jan Philip Wurm et al.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2019)

Article Biotechnology & Applied Microbiology

A prognostic 4-lncRNA expression signature for lung squamous cell carcinoma

Danju Luo et al.

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)

Article Biochemistry & Molecular Biology

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

Peng Jiang et al.

NATURE MEDICINE (2018)

Article Multidisciplinary Sciences

eIF4E3 acts as a tumor suppressor by utilizing an atypical mode of methyl-7-guanosine cap recognition

Michael J. Osborne et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Biochemistry & Molecular Biology

Multiple Nudix family proteins possess mRNA decapping activity

Man-Gen Song et al.

Article Multidisciplinary Sciences

Identification of Gemin5 as a Novel 7-Methylguanosine Cap-Binding Protein

Shelton S. Bradrick et al.

PLOS ONE (2009)

Article Biochemistry & Molecular Biology

An mRNA m7G cap binding-like motif within human Ago2 represses translation

Marianthi Kiriakidou et al.

Article Biochemistry & Molecular Biology

Structures of the human eIF4E homologous protein, h4EPH, in its m7 GTP-bound and unliganded forms

Pamela Rosettani et al.

JOURNAL OF MOLECULAR BIOLOGY (2007)